- Home
- IVA vs NNY Comparison
IVA vs NNY Comparison
Compare IVA & NNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IVA
- NNY
- Stock Information
- Founded
- IVA 2011
- NNY 1987
- Country
- IVA France
- NNY United States
- Employees
- IVA N/A
- NNY N/A
- Industry
- IVA Biotechnology: Pharmaceutical Preparations
- NNY Investment Managers
- Sector
- IVA Health Care
- NNY Finance
- Exchange
- IVA Nasdaq
- NNY Nasdaq
- Market Cap
- IVA 162.8M
- NNY 156.0M
- IPO Year
- IVA 2020
- NNY N/A
- Fundamental
- Price
- IVA $3.22
- NNY $8.28
- Analyst Decision
- IVA Strong Buy
- NNY
- Analyst Count
- IVA 4
- NNY 0
- Target Price
- IVA $13.25
- NNY N/A
- AVG Volume (30 Days)
- IVA 8.7K
- NNY 50.9K
- Earning Date
- IVA 03-26-2025
- NNY 01-01-0001
- Dividend Yield
- IVA N/A
- NNY 4.04%
- EPS Growth
- IVA N/A
- NNY N/A
- EPS
- IVA N/A
- NNY N/A
- Revenue
- IVA $15,243,814.00
- NNY N/A
- Revenue This Year
- IVA $18.05
- NNY N/A
- Revenue Next Year
- IVA $46.74
- NNY N/A
- P/E Ratio
- IVA N/A
- NNY N/A
- Revenue Growth
- IVA N/A
- NNY N/A
- 52 Week Low
- IVA $1.53
- NNY $7.58
- 52 Week High
- IVA $3.98
- NNY $8.87
- Technical
- Relative Strength Index (RSI)
- IVA 50.87
- NNY 57.91
- Support Level
- IVA $2.88
- NNY $8.23
- Resistance Level
- IVA $3.10
- NNY $8.33
- Average True Range (ATR)
- IVA 0.22
- NNY 0.08
- MACD
- IVA -0.01
- NNY 0.01
- Stochastic Oscillator
- IVA 30.37
- NNY 95.65
About IVA Inventiva S.A. American Depository Shares
Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.
About NNY Nuveen New York Municipal Value Fund
Nuveen New York Municipal Value Fund Inc is a diversified closed-end management investment company. Its investment objective is to provide current income exempt from both regular federal and New York state income taxes, by investing primarily in a portfolio of municipal obligations issued by state and local government authorities within the state of New York or certain U.S. territories.